Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2018-12-27 | 2020-08-10 | 70529 |
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2017-08-14 | 2018-01-19 | 19231 |
| APO-OLMESARTAN | 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216711 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2017-07-31 | 2018-01-20 | 17614 |
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2022-01-07 | 2022-02-07 | 152324 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2018-07-11 | 2020-09-01 | 55287 |
| APO-OLMESARTAN | 20MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55801 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-07-04 | 2018-11-22 | 54303 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Actual shortage | 2024-01-19 | 2024-11-14 | 216717 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-01-17 | 2018-04-23 | 36321 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-07-04 | 2020-07-11 | 54300 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-12-27 | 2020-07-11 | 70532 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2018-12-12 | 2020-07-11 | 69452 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2017-07-25 | 2017-11-17 | 16895 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Actual shortage | 2024-01-19 | 2024-11-14 | 216723 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-09-16 | 216720 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16900 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16905 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2017-05-30 | 2017-06-30 | 11567 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-11-20 | 2021-09-01 | 99317 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |